Sagimet Biosciences Provides Strategic and Corporate Updates
· sagimet biosciences inc.
AI Briefing
- Sagimet Biosciences announces Phase 3 clinical trial of denifanstat for moderate to severe acne
- Denifanstat clinical trial planned for second half of 2026
- Sagimet Biosciences provides strategic and corporate updates
Advertisement